Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 234   

Articles published

SNY 46.61 -0.12 (-0.26%)
price chart
Cerdelga by Genzyme Corporation of Sanofi SA (ADR) (NYSE:SNY)
Genzyme Corporation, which is a biotechnology company based in Massachusetts and a subsidiary of Sanofi SA (ADR) (NYSE:SNY), made it public that it has developed a drug as a cure for type 1 of Gaucher disease (GD1).
First Call Rating Update on Sanofi SA (ADR)
Sanofi SA (ADR) (NYSE:SNY) has received a Buy rating from First Call in their declaration. The rating agency has disclosed the information in the equity research recommendation.
Sanofi SA (ADR) Witness Large Inflow of Money
Sanofi SA (ADR) (NYSE:SNY) dropped -0.98% or -0.46 points to trade at $46.42 per share. As per the latest trading data available, the net money flow stood at $2.02 million as the counter received $2.98 million in upticks and gave away $0.96 million in ...
Sanofi SA Downgraded by Kepler Capital Markets (SNY)  The Legacy
Stocks Appreciate for the Week: Netflix Inc , Sanofi SA  Winston View
Sanofi SA (ADR) (SNY) Trading at Discount to Fair Value
�What it really all came down to, last quarter they reported disappointing guidance for their diabetes franchise, and probably even more importantly what affected the stock was that the CEO was fired due to conflicts with the board of directors of the ...
Has Sanofi SA (ADR) (NYSE:SNY) Fallen Enough?
Sanofi's diabetes franchise appears to be in trouble, with its drug Lantus facing increased competition. The company has projected flat sales for its diabetes offerings, in great part due to increased generic competition when Lantus loses its patent ...
Sanofi SA (ADR) (NYSE:SNY)Receives Approval For Marketing Gaucher ...
Effective March 5, 2014, Sanofi SA (ADR) (NYSE:SNY) of France acquired an undisclosed minority stake in Regulus Therapeutics Inc. Shares of the Paris-based firm are down more than 21 percent since late September 2014.
Sanofi SA (SNY) Gaucher Disease Drug Cerdelga Wins EU Approval  Bidness ETC
Sanofi SA (ADR) (SNY) And Netflix, Inc. (NFLX) Executives Entangled In ...
When Sanofi SA (ADR) (NYSE:SNY) CEO Christopher Viehbacher was sacked recently, it was believed that the disagreement between him and the board was the reason of his unfortunate exit.
Whistleblower Lawsuit Accuses Sanofi SA (SNY), Ousted CEO Of Kickback ...
Sanofi SA (ADR) (NYSE:SNY) has found itself caught in a whistleblower lawsuit, where a former employee is accusing the company of funneling $34 million in kickbacks and incentive payments to various doctors and pharmacies, influencing them to prescribe ...
Related articles »  
Sanofi SA (SNY) Outsources Research Facility To Evotec (EVTCY)
Sanofi SA (ADR) (NYSE:SNY) is reportedly in exclusive talks with Hamburg-based Evotec AG (ADR) (OTCMKTS:EVTCY) to transfer its research operations in Toulouse, France to the German drug-maker.
Related articles »  
Sanofi SA (SNY) Continues Search For Head; Smith & Nephew (SNN) CEO Out ...
In an employee meeting, Smith & Nephew plc (ADR) (NYSE:SNN) Chief Executive Olivier Bohuon dismissed rumors of his plans to leave the medical-device maker to join Sanofi SA (ADR) (NYSE:SNY), as per reports from Bloomberg. This implies that Sanofi, ...
Related articles »